help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Day, R. M.
Right arrow Articles by Lanzillo, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Day, R. M.
Right arrow Articles by Lanzillo, J. J.

Am. J. Respir. Cell Mol. Biol., Volume 25, Number 5, November, 2001 613-619

Bleomycin Upregulates Gene Expression of Angiotensin-Converting Enzyme via Mitogen-Activated Protein Kinase and Early Growth Response 1 Transcription Factor

Regina M. Day, Yongzhen Yang, Yuichiro J. Suzuki, Joanne Stevens, Renuka Pathi, Amy Perlmutter, Barry L. Fanburg, and Joseph J. Lanzillo

New England Medical Center, Tupper Research Institute, Pulmonary and Critical Care Division; and Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts

Pulmonary fibrosis is a progressive disorder characterized by the loss of alveolar architecture through epithelial and endothelial cell apoptosis and fibroblast proliferation. Recent studies showed that angiotensin-converting enzyme (ACE) activity is increased in fibrotic tissues, and ACE inhibitors administered in vivo ameliorate fibrosis, suggesting that ACE may play a critical role. However, the regulation of ACE expression is not well understood. In the present study, we demonstrate that bleomycin, a chemotherapeutic agent which induces pulmonary fibrosis in animals and humans, increases gene expression of ACE. Treatment of primary bovine pulmonary artery endothelial cells with 0.1 to 1.0 µg/ml bleomycin increased ACE enzymatic activity and ACE mRNA, as monitored by hippuryl-L-histidyl-L-leucine assay and competitive quantitative reverse transcriptase polymerase chain reaction (RT-PCR), respectively. Luciferase reporter constructs showed that upregulation of ACE transcription by bleomycin is mediated through element(s) in the 97-bp ACE promoter. Bleomycin activated p42/p44 mitogen-activated protein kinase (MAPK) and induced nuclear translocation and activation of the early growth response (Egr)-1 transcription factor, a factor previously shown to positively regulate ACE expression. The MAPK kinase1/2 (MEK1/2) inhibitor U0126 blocked MAPK and Egr-1 activation by bleomycin, suggesting that Egr-1 activation is MAPK dependent. These data provide the first evidence that bleomycin activates ACE gene expression through the MAPK pathway and Egr-1.


Abbreviations: angiotensin converting enzyme, ACE; angiotensin II, Ang II; bovine pulmonary artery endothelial cells, BPAEC; complementary DNA, cDNA; deoxynucleoside triphosphate, dNTP; dithiothreitol, DTT; ethylenediaminetetraacetic acid, EDTA; early growth response 1, Egr-1; electrophoretic mobility shift assay, EMSA; hepatocyte growth factor, HGF; human umbilical vein endothelial cells, HUVEC; nitro-L-arginine methyl ester, L-NAME; mitogen-activated protein kinase, MAPK; MAPK kinase1/2, MEK1/2; Moloney murine leukemia virus reverse transcriptase, MMLV-RT; phosphate-buffered saline, PBS; polymerase chain reaction, PCR; phorbol 12-myristate acetate, PMA; platelet-derived growth factor, PDGF; phenylmethylsulfonyl fluoride, PMSF; reactive oxygen species, ROS; transforming growth factor-beta 1, TGF-beta 1.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Watanabe, W. Matsuyama, Y. Shirahama, H. Mitsuyama, K.-i. Oonakahara, S. Noma, I. Higashimoto, M. Osame, and K. Arimura
Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation
J. Immunol., May 1, 2007; 178(9): 5888 - 5898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Chen, H. Ning, W. Ishida, S. Sodin-Semrl, S. Takagawa, Y. Mori, and J. Varga
The Early-Immediate Gene EGR-1 Is Induced by Transforming Growth Factor-beta and Mediates Stimulation of Collagen Gene Expression
J. Biol. Chem., July 28, 2006; 281(30): 21183 - 21197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Day, G. Thiel, J. Lum, R. D. Chevere, Y. Yang, J. Stevens, L. Sibert, and B. L. Fanburg
Hepatocyte Growth Factor Regulates Angiotensin Converting Enzyme Expression
J. Biol. Chem., March 5, 2004; 279(10): 8792 - 8801.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Li, H. Zhang, V. Soledad-Conrad, J. Zhuang, and B. D. Uhal
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo
Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L501 - L507.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Li, R. M. Singh, L. Liu, H. Chen, B. M. Singh, N. Kazzaz, and J. L. Mehta
Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells
Cardiovasc Res, January 1, 2003; 57(1): 238 - 243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Koval
Sharing signals: connecting lung epithelial cells with gap junction channels
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L875 - L893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Day, Y. j. Suzuki, J. M. Lum, A. C. White, and B. L. Fanburg
Bleomycin upregulates expression of gamma -glutamylcysteine synthetase in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1349 - L1357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2001 American Thoracic Society.